View More Recent Stories
-
Inspire Medical Systems (INSP) Announces $150M Share Buyback
-
Inspire Medical Systems (INSP) Announces FDA Approval of the Inspire V System
-
Inspire Medical Systems (INSP) Announces FDA Approval of the Inspire V System
-
Inspire Medical Systems (INSP) PT Lowered to $230 at Jefferies
-
Inspire Medical Systems (INSP) raises guidance
-
Inspire Medical Systems (INSP) Announces Countrywide Reimbursement in France
-
Inspire Medical Systems (INSP) Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
-
Inspire Medical Systems (INSP) PT Lowered to $217 at Truist Securities
-
Inspire Medical Systems (INSP) PT Lowered to $220 at Baird
-
Inspire Medical Systems (INSP) PT Lowered to $200 at Mizuho
-
Piper Sandler Reiterates Overweight Rating on Inspire Medical Systems (INSP)
-
ResMed, Inspire Medical slump after Lilly's positive Zepbound data; Citi downgrades
-
ResMed (RMD), Inspire Medical (INSP) sink following Lilly's sleep apnea results
-
Inspire Medical Systems (INSP) PT Lowered to $170 at Stifel Following Lilly's SURMOUNTOSA data
-
Inspire Medical Systems (INSP) PT Lowered to $175 at CFRA
-
6 MedTech stocks to own - KeyBanc

